-
Cancer Survivors Predicted to Top 22 Million by 2030
drugs
June 12, 2019
Cancer Survivors Predicted to Top 22 Million by 2030.
-
Location of Body Fat Linked to Advanced, Fatal Prostate Cancer
drugs
June 11, 2019
Location of Body Fat Linked to Advanced, Fatal Prostate Cancer.
-
ASCO: Enzalutamide Beneficial in Metastatic Prostate Cancer
drugs
June 06, 2019
Enzalutamide Beneficial in Metastatic Prostate Cancer.
-
Few Prostate Cancer Patients Are Getting Checkups They Need
drugs
June 06, 2019
Few Prostate Cancer Patients Are Getting Checkups They Need.
-
Fragmentation Profiles of Cell-Free DNA Can Detect Cancer
drugs
June 06, 2019
Fragmentation Profiles of Cell-Free DNA Can Detect Cancer.
-
Lynparza reduces PFS in germline BRCA-mutated pancreatic cancer
pharmaceutical-technology
June 05, 2019
AstraZeneca and Merck have announced that Lynparza (olaparib) demonstrated significant improvement in progression-free survival (PFS), compared to placebo, in germline BRCA-mutated metastatic .adenocarcinoma of the pancreas.
-
Pembrolizumab trumps chemotherapy in recurrent head and neck cancer
pharmaceutical-technology
June 05, 2019
Research has shown that immunotherapy pembrolizumab alone and in combination with chemotherapy is a more efficacious first line treatment for head and neck cancer that has returned than aggressive chemotherapy.
-
Health Tip: Understanding Liver Spots
drugs
June 05, 2019
Understanding Liver Spots.
-
Is MRI Screening Worth It for Breast Cancer Survivors?
drugs
June 05, 2019
Breast MRI screening is a good way to detect small tumors, but it's unclear how much it benefits women with a history of breast cancer, a new study finds.
-
Testicular Cancer Treatment Unlikely to Trigger Birth Defects
drugs
June 05, 2019
Testicular Cancer Treatment Unlikely to Trigger Birth Defects.